IPSEN (OTCMKTS:IPSEY) Shares Gap Up – Here’s Why

Shares of IPSEN (OTCMKTS:IPSEY) gapped up prior to trading on Wednesday . The stock had previously closed at $34.93, but opened at $36.3596. IPSEN shares last traded at $36.3596, with a volume of 136 shares traded.

Analysts Set New Price Targets

A number of brokerages recently commented on IPSEY. BNP Paribas lowered IPSEN to an “underperform” rating in a research note on Wednesday, November 26th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of IPSEN in a research note on Monday, November 3rd. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, IPSEN currently has a consensus rating of “Hold”.

IPSEN Price Performance

The business has a 50-day simple moving average of $35.80 and a two-hundred day simple moving average of $33.57.

IPSEN Company Profile

Ipsen is a global biopharmaceutical company headquartered in Boulogne-Billancourt, France. Founded in 1929, the company focuses on specialty care areas including oncology, neuroscience and rare diseases. Ipsen develops, manufactures and commercializes innovative medicines that address critical unmet medical needs, offering a diverse portfolio of therapies for both adult and pediatric patient populations.

The company’s oncology franchise includes treatments for prostate, renal and hepatocellular carcinomas, with key products such as Cabometyx (cabozantinib) and Decapeptyl (triptorelin).